Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with Concurrent Chemoradiation in Unresectable Stage III NSCLC
NCT01503385Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Dec 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in non-small cell lung cancer (NSCLC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
celecoxib oral solution
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01503385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01503385.